SCIO is a leading provider of advanced healthcare analytics and performance optimization solutions to organizations across the healthcare continuum, including payers, providers, PBMs, employers, and global life sciences companies. Through it’s technology-enabled offerings, the Company assists clients in identifying and resolving underlying issues that lead to excessive spending and suboptimal health outcomes. The Company’s enterprise analytics transform data into actionable insights, helping clients improve outcomes, reduce costs, and improve the healthcare experience.
TripleTree was engaged by SCIO’s board – including its lead investors Sequoia Capital and Health Enterprise Partners as well as key members of the executive management team – as the Company’s exclusive strategic and financial advisor given its intimate knowledge of the payment integrity and care optimization landscape, coupled with its exceptional track record and hands-on approach to executing successful transactions. TripleTree worked closely with the SCIO management team to position the Company’s robust capabilities within a complex care and cost optimization competitive landscape, highlighting the versatility and value inherent in its enterprise analytics platform to a broad range of industry constituents.
SCIO signed a definitive agreement to be acquired by EXL in a competitive process that considered a range of both strategic and financial sponsor alternatives. At a purchase price of $240 million, the transaction represents one of the largest and most significant healthcare analytics transactions in 2018. Together, the combined business is well-positioned to provide a broad range of strategic solutions designed to drive revenue, manage costs, and improve operational performance across the enterprise.
Read full press release from SCIO Health Analytics.
Read full press release from EXL.
Read full press release from TripleTree.